The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.
The proposed study is a placebo-controlled, add-on, randomized trial using parallel group
designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation
ratio and superiority framework.
Drug: Iodine Complex
Iodine Complex capsule (200mg) will be given three times a day
Drug: Iodine Complex
Iodine Complex syrup form (40ml) will be given three times a day
Drug: Placebo
Empty capsule will be given as placebo
Other Name: capsule
Drug: Idoine Complex
Iodine Complex spray form 2 puffs will be given three times a day
Inclusion Criteria:
- Positive PCR with mild to moderate disease
Exclusion Criteria:
- Allergic to iodine
- Any co-morbidity other than hypertension and dietetics
Shaikh Zayed Hospital
Lahore, Pakistan
Investigator: Sohaib Ashraf, MBBS
Contact: +923334474523
sohaib@skzmdc.edu.pk
Investigator:
Sohaib Ashraf, MBBS
+923334474523
sohaib-ashraf@outlook.com
Shoaib Ashraf, PhD
+16177949579
sashraf@mgh.harvard.edu